According to the report, the Global Circulating Tumor Cells Market was valued at USD 9.39 billion in 2017 and is expected to rise to a valuation of USD 28.3 billion by the end of 2023. Market Research Future (MRFR) has announced a new release on the global circulating tumor cell market. The report presents a detailed analysis of the market’s likely growth trajectory and drivers over the forecast period from 2018 to 2023, based on a solid examination of the CTC market’s growth over the past few years.
Circulating tumor cells (CTC) are cancerous cells that break off from the original site of the cancer and spread throughout the body through the vascular system. These cells thus act as the “seed” for cancer metastases. The highly adverse prognosis for cancer with metastasis has resulted in an increasing interest in circulating tumor cells, as they can act as an early warning system for cancer metastasis. The clinical significance of circulating tumor cells was first recognized in 1869, but serious medical research within the context of the modern structure of the healthcare sector began in the 1990s. These studies were inspired by calculations that showed that even small cancerous growths shedding cells at a small rate of less than 1% per day would produce enough circulating tumor cells in the bloodstream to be detectable.
Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/1362
The growing prevalence of cancer is likely to be the major driver for the global circulating tumor cell market over the forecast period. Over 90% of the deaths caused by cancer are caused by cancers that have metastasized, leading to the field of circulating tumor cells taking on a highly important position in modern oncology. Circulating tumor cells can thus be used as an early warning of progressive cancer; the growing clamor for advances in cancer prevention rather than treatment is expected to drive the circulating tumor cells market over the forecast period. Circulating tumor cells also provide the perfect way to monitor the development of a cancer in an individual, as simple blood tests can be used in place of invasive biopsies to measure the prevalence of CTCs as the disease progresses.
Circulating Tumor Cells Market Competitive Analysis:
Leading players in the global circulating tumor cells market include Ikonisys Inc., Thermo Fisher Scientific, STEMCELL Technologies, Menarini Silicon Biosystems, F. Hoffman-La Roche Ltd., Fluxion Biosciences Inc., ApoCell, Epic Lifesciences, Celltraffix Inc., Advanced Cell Diagnostics Inc. (Bio-Techne Corporation), GE Healthcare, NanoString Technologies Inc., QIAGEN, Miltenyi Biotec, SRI International, and Greiner Bio-One International GmbH.
Circulating Tumor Cells Market Segmentation:
The global circulating tumor cells market is segmented by
technology
application
end use
region
The global circulating tumor cell market is segmented based on technology into
CTC enrichment
CTC detection
combined enrichment
separation of CTC
Based on application, the global CTC market is segmented into
clinical
research
drug development
By end use, the CTC market is segmented into
hospitals & clinics
research & academic institutes
diagnostic centers
Circulating Tumor Cells Market Regional Analysis:
The global CTC market is segmented based on region into
North America
South America
Europe
Asia Pacific
Middle East
Africa
North America is likely to be the dominant regional market for circulating tumor cell research and technology over the forecast period. The highly advanced state of the healthcare sector in North America is a major factor conducive for steady growth of the circulating tumor cell market in the region. The growing prevalence of cancer in North America and the increasing efforts to update and enhance the means to combat the same are likely to result in a steady growth in demand from the circulating tumor cell market in the region.
Asia Pacific is also expected to exhibit steady growth in the global circulating tumor cells market over the forecast period due to the increasing healthcare expenditure in emerging countries in the region and the increasing prevalence of cancer.
Browse Full Report Details at: https://www.marketresearchfuture.com/reports/circulating-tumor-cell-market-1362
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: www.marketresearchfuture.com/reports/circulating-tumor-cell-market-1362